Bank of Montreal Can Acquires 1,566 Shares of Teleflex Incorporated $TFX

Bank of Montreal Can grew its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 12.9% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 13,665 shares of the medical technology company’s stock after acquiring an additional 1,566 shares during the quarter. Bank of Montreal Can’s holdings in Teleflex were worth $1,617,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in TFX. Allworth Financial LP increased its position in Teleflex by 504.8% during the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 212 shares during the period. New York State Common Retirement Fund boosted its stake in shares of Teleflex by 5.1% during the 1st quarter. New York State Common Retirement Fund now owns 25,639 shares of the medical technology company’s stock valued at $3,543,000 after purchasing an additional 1,239 shares in the last quarter. Signaturefd LLC increased its position in shares of Teleflex by 38.3% during the first quarter. Signaturefd LLC now owns 433 shares of the medical technology company’s stock valued at $60,000 after buying an additional 120 shares during the period. Verdence Capital Advisors LLC raised its stake in Teleflex by 58.6% in the first quarter. Verdence Capital Advisors LLC now owns 3,061 shares of the medical technology company’s stock worth $423,000 after buying an additional 1,131 shares in the last quarter. Finally, Calton & Associates Inc. purchased a new stake in Teleflex in the first quarter worth about $132,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of NYSE:TFX opened at $109.47 on Friday. The business has a fifty day moving average price of $124.31 and a 200-day moving average price of $122.48. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. The company has a market capitalization of $4.84 billion, a PE ratio of 25.76, a PEG ratio of 1.79 and a beta of 1.05. Teleflex Incorporated has a 1-year low of $102.58 and a 1-year high of $195.47.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.38 by $0.29. The company had revenue of $892.90 million for the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. Teleflex’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same period in the prior year, the firm posted $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 14th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.2%. Teleflex’s dividend payout ratio (DPR) is -18.50%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on TFX shares. Wall Street Zen downgraded Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. Zacks Research cut Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Wells Fargo & Company lowered their price objective on Teleflex from $131.00 to $114.00 and set an “equal weight” rating for the company in a research report on Friday, November 7th. Royal Bank Of Canada reduced their target price on shares of Teleflex from $135.00 to $120.00 and set a “sector perform” rating on the stock in a research report on Friday, November 7th. Finally, Truist Financial decreased their price target on shares of Teleflex from $128.00 to $120.00 and set a “hold” rating for the company in a research note on Monday. One analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Teleflex currently has an average rating of “Reduce” and a consensus target price of $134.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.